Valence 로고
인기
로그인
Loading data for CINGW — first visit, this takes a few seconds.

관심목록에 추가

Cingulate Inc.

NasdaqCM: CINGW · 실시간 가격 · USD
0.01
+0.00 (0.00%)
종가 기준: Aug 19, 2026, 3:49 PM

Cingulate Inc. (CINGW) Stock Price, Analysis & Data

0.00%
매수호가n/a
시가총액n/a
매출 (ttm)n/a
순이익 (ttm)-28.81M
베타-0.91
EPS (ttm)-1.73
P/E (ttm)n/a
선행 P/En/a
P/B (ttm)0.03
P/S (ttm)n/a
Earnings Daten/a
매도호가n/a
거래량201
평균 거래량 (20일)
시가0.04
전일 종가0.01
일중 범위0.01 - 0.01
52주 범위0.01 - 0.01
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

CINGW 소개

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a f...

[더 보기]
산업
섹터
IPO 일자 Jul 17, 2026
직원 수 14
상장 거래소 NasdaqCM
티커 CINGW
웹사이트 https://www.cingulate.com
전체 기업 정보

재무 실적

2025년 Cingulate의 매출은 0로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -22.45M로, 35.57% 증가했습니다.

재무제표
news image

3개월 전 · Insider Monkey

Here is Why Cingulate (CING) is One of the Best NASDAQ Growth Stocks to Buy and Hold Forever

Cingulate Inc. (NASDAQ:CING) is one of the best NASDAQ growth stocks to buy and hold forever. On March 18, Cingulate reported its financial results for Q4 and the full year 2025, highlighting the rece...